النظرة الحديثة لتشخيص وعلاج التهاب المثانة الحاد البدئي عند النساء
Abstract
شملت الدراسة 84 مريضة مصابة بالتهاب مثانة حاد بدئي في مشفى الأسد الجامعي باللاذقية بين عامي 2004 - 2006.
قسم هذا العدد إلى مجموعتين متساويتين. عولجت المجموعة الأولى بالنورفلوكساسين لمدة خمسة أيام. والمجموعة الثانية أيضاً بالنورفلوكساسين ولكن لمدة عشرة أيام. وأجريت مقارنة علاج المجموعتين.
أكثر الجراثيم تسبياً بالتهاب المثانة الحاد البدئي كانت E.coli حيث وجدت عند 73 مريضة (86.9%). عدد الحالات المقاومة للنورفلوكساسين بلغت 8 حالات (9.52%) من مجموع الحالات.
تم الحصول على نتيجة ايجابية عند 75مريضة (89.28%) من مجموع الحالات المعالجة. لم نجد فارقاً كبيراًً بين معالجة مريضات المجموعة الأولى لمدة خمسة أيام ومعالجة مريضات المجموعة الثانية لمدة عشرة أيام. ولمعالجة التهاب المثانة الحاد البدئي تكفي خمسة أيام لزوال الأعراض السريرية والتغيرات في فحص البول والراسب.
The study covered 84 women of primary acute cystitis in Al-Assad University Hospital in Lattakia in 2004-2006. This number was divided into two equal groups. The first group was treated with Norfloxacine 400 mg for five days. The second group was also treated with Norfloxacine 400 mg but for 10 days. There had been a comparison between the two treatments. Most of germs which caused the primary acute cystitis were E. coli. They had been found in 73 women (86.9%). There had been 8 cases (9.52% of the total cases) which resisted Norfloxacine 400 mg. A positive result was obtained in 75 women (89.28% of the total treated cases). There was a big difference between the treatment of the first group for 5 days and the treatment of the second group for 10 days. Consequently, 5 days are enough for to get rid of the clinic symptoms and the changes in examining urine and deposit.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.